TANG CAPITAL PARTNERS LP
Related Filers (96)
- TANG CAPITAL MANAGEMENT LLC (205)
- TANG KEVIN C (202)
- PENWEST PHARMACEUTICALS CO (63)
- LA JOLLA PHARMACEUTICAL CO (54)
- Ardea Biosciences, Inc./DE (50)
- HERON THERAPEUTICS, INC. /DE/ (50)
- Odonate Therapeutics, Inc. (39)
- Vanda Pharmaceuticals Inc. (31)
- Lemkey John G (29)
- Northstar Neuroscience, Inc. (24)
- Hearne Michael S (21)
- NEOSE TECHNOLOGIES INC (17)
- THRESHOLD PHARMACEUTICALS INC (13)
- Aptevo Therapeutics Inc. (11)
- ARADIGM CORP (10)
- TCR2 THERAPEUTICS INC. (10)
- Cyclacel Pharmaceuticals, Inc. (9)
- Jounce Therapeutics, Inc. (9)
- DEPOMED INC (8)
- Rain Oncology Inc. (8)
- TAPESTRY PHARMACEUTICALS, INC (7)
- INSMED INC (5)
- QUESTCOR PHARMACEUTICALS INC (5)
- GENTA INC DE/ (5)
- Mirati Therapeutics, Inc. (5)
- Evolus, Inc. (5)
- ACLARA BIOSCIENCES INC (4)
- RXi Pharmaceuticals Corp (4)
- ONCOGENEX PHARMACEUTICALS, INC. (4)
- Theseus Pharmaceuticals, Inc. (4)
- Monogram Biosciences, Inc. (3)
- VIROPHARMA INC (3)
- CELL GENESYS INC (3)
- BIOSANTE PHARMACEUTICALS INC (3)
- NEUROGEN CORP (3)
- Galena Biopharma, Inc. (3)
- Anthera Pharmaceuticals Inc (3)
- Ignyta, Inc. (3)
- ROCKET PHARMACEUTICALS, INC. (3)
- RELMADA THERAPEUTICS, INC. (3)
- ANAPTYSBIO, INC (3)
- REVIVA PHARMACEUTICALS HOLDINGS, INC. (3)
- bluebird bio, Inc. (3)
- Corvus Pharmaceuticals, Inc. (3)
- Tonix Pharmaceuticals Holding Corp. (3)
- KalVista Pharmaceuticals, Inc. (3)
- Tarsus Pharmaceuticals, Inc. (3)
- Altimmune, Inc. (3)
- CytomX Therapeutics, Inc. (3)
- BioAtla, Inc. (3)
- Pyxis Oncology, Inc. (3)
- Aligos Therapeutics, Inc. (3)
- ASLAN Pharmaceuticals Ltd (3)
- POINT THERAPEUTICS INC (2)
- XENOGEN CORP (2)
- KERYX BIOPHARMACEUTICALS INC (2)
- OPTIMER PHARMACEUTICALS INC (2)
- ADVENTRX PHARMACEUTICALS INC (2)
- Alexza Pharmaceuticals Inc. (2)
- CELL THERAPEUTICS INC (2)
- HORIZON PHARMA, INC. (2)
- SPECTRUM PHARMACEUTICALS INC (2)
- Transcept Pharmaceuticals Inc (2)
- SUPERNUS PHARMACEUTICALS INC (2)
- Cellectar Biosciences, Inc. (2)
- Vincerx Pharma, Inc. (2)
- aTYR PHARMA INC (2)
- ALBIREO PHARMA, INC. (2)
- Metacrine, Inc. (2)
- VERU INC. (2)
- Elevation Oncology, Inc. (2)
- Adicet Bio, Inc. (2)
- Bellerophon Therapeutics, Inc. (2)
- Quince Therapeutics, Inc. (2)
- InflaRx N.V. (2)
- Bolt Biotherapeutics, Inc. (2)
- Genfit S.A. (2)
- MEI Pharma, Inc. (2)
- AVROBIO, Inc. (2)
- Transcode Therapeutics, Inc. (2)
- BIONOMICS LIMITED/FI (2)
- Aclaris Therapeutics, Inc. (2)
- Kinnate Biopharma Inc. (2)
- Atea Pharmaceuticals, Inc. (2)
- LianBio (2)
- Tharimmune, Inc. (2)
- ADVANCIS PHARMACEUTICAL CORP (1)
- PRANA BIOTECHNOLOGY LTD (1)
- MANNKIND CORP (1)
- Magenta Therapeutics, Inc. (1)
- Inspirato Inc (1)
- Reneo Pharmaceuticals, Inc. (1)
- Corbus Pharmaceuticals Holdings, Inc. (1)
- Ventyx Biosciences, Inc. (1)
- PRECISION BIOSCIENCES INC (1)
- Graphite Bio, Inc. (1)
- Show More ...
Other (2)
CORRESP
Friday, 7/25/2008
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
REGDEX
Friday, 10/11/2002
Form D (PDF)
Ownership (555)
SC 13D/A
Friday, 2/16/2024
Theseus Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
BioAtla, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
REVIVA PHARMACEUTICALS HOLDINGS, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Genfit S.A.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Pyxis Oncology, Inc.: Major Shareholders
4
Wednesday, 2/14/2024
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/14/2024
Adicet Bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Transcode Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Elevation Oncology, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Bellerophon Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
CytomX Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Tharimmune, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
InflaRx N.V.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Altimmune, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Aligos Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Evolus, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
bluebird bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Kinnate Biopharma Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Aclaris Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
KalVista Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Bolt Biotherapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Quince Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
ANAPTYSBIO, INC: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
BIONOMICS LIMITED/FI: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
TCR2 THERAPEUTICS INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Tonix Pharmaceuticals Holding Corp.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Tarsus Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
AVROBIO, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
MEI Pharma, Inc.: Major Shareholders
SC 13G
Monday, 2/5/2024
PRECISION BIOSCIENCES INC: Major Shareholders
SC 13G
Monday, 2/5/2024
Graphite Bio, Inc.: Major Shareholders
SC 13D/A
Friday, 2/2/2024
Rain Oncology Inc.: Major Shareholders
4
Friday, 2/2/2024
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 1/29/2024
Ventyx Biosciences, Inc.: Major Shareholders
SC 13G
Friday, 1/26/2024
Corbus Pharmaceuticals Holdings, Inc.: Major Shareholders
SC 13D/A
Friday, 1/12/2024
Theseus Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 1/2/2024
ASLAN Pharmaceuticals Ltd: Major Shareholders
SC 13D/A
Thursday, 12/28/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Tuesday, 12/26/2023
Reneo Pharmaceuticals, Inc.: Major Shareholders
4
Monday, 12/18/2023
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 12/7/2023
Tharimmune, Inc.: Major Shareholders
SC 13D
Thursday, 11/30/2023
LianBio: Major Shareholders
SC 13D/A
Tuesday, 11/28/2023
Atea Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Monday, 11/27/2023
Kinnate Biopharma Inc.: Major Shareholders
SC 13D
Friday, 11/24/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 11/24/2023
Aclaris Therapeutics, Inc.: Major Shareholders
SC 13G
Wednesday, 11/1/2023
LianBio: Major Shareholders
SC 13D/A
Friday, 10/13/2023
Rain Oncology Inc.: Major Shareholders
4
Friday, 10/13/2023
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 10/10/2023
BIONOMICS LIMITED/FI: Major Shareholders
SC 13G
Tuesday, 9/26/2023
Transcode Therapeutics, Inc.: Major Shareholders
SC 13G/A
Thursday, 7/13/2023
ASLAN Pharmaceuticals Ltd: Major Shareholders
SC 13G
Tuesday, 6/6/2023
AVROBIO, Inc.: Major Shareholders
SC 13D
Thursday, 6/1/2023
Rain Oncology Inc.: Major Shareholders
3
Thursday, 6/1/2023
Rain Oncology Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/1/2023
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 5/22/2023
Atea Pharmaceuticals, Inc.: Major Shareholders
4
Monday, 5/15/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Friday, 5/5/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
3
Friday, 5/5/2023
TCR2 THERAPEUTICS INC.: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 5/5/2023
TCR2 THERAPEUTICS INC.: Major Shareholders
SC 13D/A
Friday, 5/5/2023
Jounce Therapeutics, Inc.: Major Shareholders
4
Friday, 5/5/2023
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 5/1/2023
MEI Pharma, Inc.: Major Shareholders
SC 13G
Monday, 5/1/2023
Genfit S.A.: Major Shareholders
SC 13G
Thursday, 4/20/2023
Bolt Biotherapeutics, Inc.: Major Shareholders
SC 13G
Monday, 4/17/2023
InflaRx N.V.: Major Shareholders
SC 13D/A
Friday, 4/7/2023
Jounce Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 3/31/2023
Quince Therapeutics, Inc.: Major Shareholders
SC 13D/A
Tuesday, 3/28/2023
Jounce Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 3/17/2023
Bellerophon Therapeutics, Inc.: Major Shareholders
SC 13D/A
Friday, 3/17/2023
Jounce Therapeutics, Inc.: Major Shareholders
3
Tuesday, 3/14/2023
Jounce Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 3/14/2023
Jounce Therapeutics, Inc.: Major Shareholders
4
Tuesday, 3/14/2023
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 3/13/2023
Adicet Bio, Inc.: Major Shareholders
SC 13G
Monday, 3/6/2023
Jounce Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 2/24/2023
Elevation Oncology, Inc.: Major Shareholders
SC 13G
Tuesday, 2/21/2023
Evolus, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
bluebird bio, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Inspirato Inc: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Metacrine, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Tonix Pharmaceuticals Holding Corp.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
ALBIREO PHARMA, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
REVIVA PHARMACEUTICALS HOLDINGS, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
ASLAN Pharmaceuticals Ltd: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Tarsus Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
TCR2 THERAPEUTICS INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
CytomX Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
BioAtla, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
KalVista Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Altimmune, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
HERON THERAPEUTICS, INC. /DE/: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Aligos Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Pyxis Oncology, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Corvus Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
VERU INC.: Major Shareholders
SC 13G
Monday, 2/13/2023
Magenta Therapeutics, Inc.: Major Shareholders
Proxies (40)
DFAN14A
Tuesday, 2/9/2021
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 6/14/2010
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 6/11/2010
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 6/9/2010
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 6/7/2010
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 6/4/2010
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 6/4/2010
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 6/1/2010
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DEFC14A
Friday, 5/28/2010
Definitive proxy statement in connection with contested solicitations
PRRN14A
Thursday, 5/27/2010
Revised preliminary proxy statement filed by non-management
PRRN14A
Friday, 5/21/2010
Revised preliminary proxy statement filed by non-management
PREC14A
Friday, 5/7/2010
Preliminary proxy statement in connection with contested solicitations
DFAN14A
Monday, 6/8/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 6/2/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 6/1/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 5/29/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Thursday, 5/28/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 5/26/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 5/22/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 5/20/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 5/20/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 5/20/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 5/15/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 5/15/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Thursday, 5/14/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DEFC14A
Friday, 5/8/2009
Definitive proxy statement in connection with contested solicitations
PRRN14A
Monday, 5/4/2009
Revised preliminary proxy statement filed by non-management
PRRN14A
Thursday, 4/30/2009
Revised preliminary proxy statement filed by non-management
DFAN14A
Wednesday, 4/22/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PRRN14A
Tuesday, 4/14/2009
Revised preliminary proxy statement filed by non-management
PREC14A
Tuesday, 4/7/2009
Preliminary proxy statement in connection with contested solicitations
PREC14A
Monday, 3/30/2009
Preliminary proxy statement in connection with contested solicitations
DFAN14A
Monday, 3/30/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PRRN14A
Monday, 3/16/2009
Revised preliminary proxy statement filed by non-management
DFAN14A
Monday, 3/16/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 3/16/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 3/16/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 3/3/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 2/18/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 7/2/2008
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material